Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Genomics Initiates Closing of Private Placement to Net $1.3M

NEW YORK (GenomeWeb News) – Rosetta Genomics said after the close of the market on Wednesday that it has initiated the closing of a previously announced private placement that is expected to raise $1.3 million in net proceeds for the microRNA-based molecular diagnostic firm.

The company expects to issue an aggregate 2,025,001 shares of its common stock at $.75 per share. Investors also will receive Series A warrants to purchase up to an aggregate of 2,025,001 shares of Rosetta's common stock at an exercise price of $1 per share and Series B warrants to purchase up to an aggregate of 1,012,501 shares of common stock an exercise price of $.01 or ILS.04 ($.01) per share, whichever is greater.

When Rosetta announced the transaction last week, it said that it planned to sell an aggregate of 2,598,002 shares of its common stock. Today, the company said that three affiliated investors who had entered into the definitive purchase agreement to purchase 573,000 shares have told Rosetta they "do not intend to deliver payment for the shares."

Rodman & Renshaw was the exclusive placement agent for the offering.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.